Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study -- Company expects to submit ...

Eton Pharmaceuticals (ETON) announced positive results from its bioequivalence study of ET-600, a proprietary, patented oral solution of ...

Eton Pharmaceuticals' ET-600 met bioequivalence standards in a study, with an FDA filing planned for April 2025 and a ...

Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Eton Pharmaceuticals (ETON – Research Report) today. The company’s shares ...

Optime Care, a nationally recognized specialty pharmacy and an AscellaHealth Company, today announces an expanded partnership ...

Sebastian Stan is one of the most well-known and most recognizable faces in Hollywood thanks to his run in the Marvel ...

DEER PARK, Ill. - Eton Pharmaceuticals, Inc. (NASDAQ:ETON), a $377 million market cap pharmaceutical company whose stock has surged over 227% in the past year, has announced the successful ...

For nearly a quarter of a century, Tom Dunbar has ruled the game of Eton Fives. The sport, a form of handball which is largely the preserve of Britain’s top private schools, is played on a court ...

March 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing ...